These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 28083914)
1. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents. Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents. Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives. Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891 [TBL] [Abstract][Full Text] [Related]
4. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action. Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902 [TBL] [Abstract][Full Text] [Related]
5. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity. Rajesh SM; Kumar RS; Libertsen LA; Perumal S; Yogeeswari P; Sriram D Bioorg Med Chem Lett; 2011 May; 21(10):3012-6. PubMed ID: 21498077 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis. Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial and antitubercular agents. Joshi SD; Vagdevi HM; Vaidya VP; Gadaginamath GS Eur J Med Chem; 2008 Sep; 43(9):1989-96. PubMed ID: 18207286 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents. Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496 [TBL] [Abstract][Full Text] [Related]
9. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis. Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139 [TBL] [Abstract][Full Text] [Related]
10. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids. Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670 [TBL] [Abstract][Full Text] [Related]
11. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking. Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644 [TBL] [Abstract][Full Text] [Related]
12. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis. Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337 [TBL] [Abstract][Full Text] [Related]
13. Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents. Roh J; Karabanovich G; Vlčková H; Carazo A; Němeček J; Sychra P; Valášková L; Pavliš O; Stolaříková J; Klimešová V; Vávrová K; Pávek P; Hrabálek A Bioorg Med Chem; 2017 Oct; 25(20):5468-5476. PubMed ID: 28835350 [TBL] [Abstract][Full Text] [Related]
14. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis. Shanmugavelan P; Nagarajan S; Sathishkumar M; Ponnuswamy A; Yogeeswari P; Sriram D Bioorg Med Chem Lett; 2011 Dec; 21(24):7273-6. PubMed ID: 22061642 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and tuberculostatic activity of some (4-phenylpiperazin-1-ylmethyl)-1,3,4-oxadiazole and (4-phenylpiperazin-1-ylmethyl)-1,2,4-triazole derivatives. Foks H; Pancechowska-Ksepko D; Janowiec M; Zwolska Z; Augustynowicz-Kopeć E Acta Pol Pharm; 2004; 61(6):473-6. PubMed ID: 15794341 [TBL] [Abstract][Full Text] [Related]
16. Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents. Ahsan MJ; Samy JG; Khalilullah H; Nomani MS; Saraswat P; Gaur R; Singh A Bioorg Med Chem Lett; 2011 Dec; 21(24):7246-50. PubMed ID: 22071303 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure determination of some oxadiazole-2-thione and triazole-3-thione galactosides. Ahmad R; Iqbal R; Akhtar H; Zia-ul-Haq ; Duddeck H; Stefaniak L; Sitkowski J Nucleosides Nucleotides Nucleic Acids; 2001 Sep; 20(9):1671-82. PubMed ID: 11580193 [TBL] [Abstract][Full Text] [Related]
18. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity. Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents. Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346 [TBL] [Abstract][Full Text] [Related]
20. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain. Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]